181 - Can Ampoule Drug Delivery Systems REVOLUTIONIZE the Industry?

Let's Combinate · 26 Mar 2025 · 20m

What this episode covers

Eric Sugalski, Founder and CTO of Archimedic, discusses the Ampule Filled Syringe (AFS) system developed by his company Ampulous, which aims to combine the stability of ampules with the usability of pre-filled syringes. He explains that while pre-filled syringes (PFS) are preferred for usability, the high cost ($5M–$50M) and long timeline (18 months to several years) of transitioning from vials prevent many pharmaceutical companies from making the switch. Sugalski details how AFS decouples drug filling from device assembly, allowing the ampule to be filled separately and inserted into the syringe later, thereby bypassing the complex and expensive PFS manufacturing infrastructure. The conversation covers the technical challenges of glass particulate, heat-sensitive biologics, and human factors, as well as the historical context of ampule usage globally versus in the US.

Other shows on the same ground, closest first.

  • Being an Engineer · 20m

    S6E51 Eric Richins | What It's Like Being A Packaging Engineer

    Eric Richins, a packaging engineer at Stryker with 10 years of experience, explains the complexities of medical device packaging, distinguishing between primary, secondary, and tertiary layers and the critical role of the Tyvek sterile barrier. He details the regulatory hurdles of sterilization methods like ethylene oxide and gamma radiation, and the massive documentation required for validating automated packaging lines. Richins discusses the challenges of implementing new automation, such as a carton erector that increased throughput from 400 units in three hours to one every six seconds, while managing the gap between design intent and production reality.

  • People of Packaging · 35m

    323 - Nerding Out on Medical Packaging & Ditching PVC with Keith Smith of Vonco

    Keith E. Smith, President of Vonco Products, explains how his company is helping medical device manufacturers transition away from PVC by using proprietary technology to weld polypropylene on existing radio frequency (RF) equipment. He details the regulatory and supply chain challenges of replacing PVC in blood and IV bags, noting that material changes affect shelf life and require extensive validation. Smith also discusses how Extended Producer Responsibility (EPR) laws and tariffs on materials like foil are driving innovation toward more sustainable, single-stream plastic solutions and refill pouches for consumer goods.

  • Global Medical Device Podcast · 46m

    Why the PMA Process is so Dreaded by Manufacturers in the US Market

    David Pudwill, known as Mr. Regulatory, explains why the FDA's Premarket Approval (PMA) pathway for Class III medical devices is feared by manufacturers due to its high cost, long timelines, and uncertainty. He contrasts the PMA process with 510(k) and De Novo pathways, highlighting that PMAs require substantial clinical data and carry significant user fees, such as $366,000 for original submissions. Pudwill advises companies to consider strategic alternatives, such as using lower-risk classifications for initial revenue generation or leveraging the Pre-Submission program to engage with the FDA early in development.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.